Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Issued (2021)

Design Therapeutics' Shares Issued history spans 1 years, with the latest figure at $254.3 million for Q3 2021.

  • For Q3 2021, Shares Issued changed N/A year-over-year to $254.3 million; the TTM value through Dec 2021 reached $254.3 million, changed N/A, while the annual FY2025 figure was $24.8 million, N/A changed from the prior year.
  • Shares Issued for Q3 2021 was $254.3 million at Design Therapeutics, up from -$254.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $254.3 million in Q1 2021 and bottomed at -$254.3 million in Q2 2021.